EMI Options available. Ends SoonBook Now
Iswarya Fertility Centre & Women's Hospital
Fertility

Why Some Embryos Simply Won't Implant — Understanding the Uterine Side of Recurrent Implantation Failure

Medically Reviewed by Dr. Arun Muthuvel
📅23 Jul 2026

Listen to this article

Tap play — works on desktop and mobile

When good embryos keep failing to implant, the uterus itself may hold the answer. Here's what patients need to know about the uterine factors behind RIF.

When the Embryo Isn't the Problem

For many patients going through IVF, the assumption is that if the embryo is good — graded well, chromosomally tested, transferred at the right stage — it will implant. So when it doesn't, once, twice, sometimes three times or more, the confusion and heartbreak can be overwhelming.

Recurrent implantation failure (RIF) is generally defined as the failure to achieve a clinical pregnancy after two or more transfers of good-quality embryos. It affects a meaningful number of IVF patients, and while embryo quality is always part of the conversation, there is another side of the equation that often goes underexplored: the uterus itself.

The endometrium — the lining of the uterus — has to do something remarkable during an implantation cycle. It has to transform into a receptive environment during a very narrow window of time, and that window has to align precisely with when the embryo is ready to attach. When that alignment doesn't happen, even a healthy embryo has no chance.

What Makes the Uterus Receptive — and What Can Go Wrong

Uterine receptivity is not simply about lining thickness, though that matters. It involves a complex interplay of hormones, immune activity, blood flow, structural integrity, and molecular signalling — all of which have to work in concert.

Here are the key uterine factors that can contribute to recurrent implantation failure:

  • Endometrial polyps: Small, benign growths in the uterine cavity that can physically interfere with where an embryo tries to attach. Many women with polyps have no symptoms at all, and they are only discovered during investigation.
  • Submucosal fibroids: Fibroids that grow into the uterine cavity can distort its shape and alter the environment the endometrium creates. Not all fibroids affect implantation, but those inside the cavity often do.
  • Uterine septum or other structural anomalies: A uterine septum — a wall of tissue dividing part of the cavity — can reduce blood supply to the endometrium and make implantation less likely. These are congenital and often go undetected without a targeted investigation.
  • Thin or poorly developed endometrium: A lining that doesn't thicken adequately, or doesn't develop the right texture on ultrasound, can fail to support implantation even when everything else appears normal.
  • Chronic endometritis: This is a low-grade, persistent inflammation of the uterine lining caused by bacterial infection. It does not always cause pain or obvious symptoms, but studies have found it in a significant proportion of women with RIF. It is treatable with antibiotics once diagnosed via endometrial biopsy.
  • Displaced implantation window: Even when the lining looks healthy, the precise timing of when it is most receptive — the window of implantation — can shift. For some women, this window occurs earlier or later than expected, meaning a transfer timed to standard protocols misses it entirely.

The Window of Implantation — and Why Timing Is Everything

In a natural cycle, the window of implantation typically opens around days 20 to 24. In a medicated frozen embryo transfer cycle, it is assumed to open at a predictable point based on progesterone exposure. But for some women, this assumption is simply wrong.

The Endometrial Receptivity Analysis (ERA) test was developed specifically to address this. It involves taking a small biopsy of the endometrium at the expected time of receptivity and analysing the expression of hundreds of genes associated with implantation readiness. The result classifies the endometrium as receptive, pre-receptive, or post-receptive — and if it falls outside the expected window, the transfer timing can be personalised accordingly.

At Iswarya Fertility, ERA testing is offered as part of a thorough RIF investigation protocol, particularly for patients who have experienced repeated failures with good-quality embryos and no obvious explanation. It has helped identify displaced implantation windows that would otherwise have continued to be missed.

Immune Factors That Are Often Overlooked

The immune environment of the uterus is another area that warrants attention in RIF cases. For an embryo to implant, the immune system has to do something counterintuitive — it has to tolerate a genetically foreign entity. When that immune tolerance doesn't develop properly, implantation can fail.

Natural killer (NK) cells in the uterine lining play a key role in regulating this response. An imbalance — either too many or too few, or cells that behave abnormally — has been associated with implantation failure and early pregnancy loss. Antiphospholipid syndrome, an autoimmune condition that affects blood clotting, is another immune-related cause that can prevent a pregnancy from establishing properly even after implantation begins.

These factors require specialist blood tests and sometimes uterine immunological assessment to identify. They are not part of a standard IVF workup, which is why many patients are not tested unless they specifically present with RIF.

What an RIF Investigation Should Look Like

If you have experienced two or more failed transfers with good embryos, a structured investigation is not just reasonable — it is necessary. A thorough evaluation should include:

  1. 3D ultrasound or hysteroscopy to assess the uterine cavity for structural problems
  2. Endometrial biopsy to check for chronic endometritis
  3. ERA test to assess timing of the implantation window
  4. Blood tests for thrombophilia, antiphospholipid antibodies, and thyroid function
  5. Review of stimulation and transfer protocol to assess whether adjustments are needed

The team at Iswarya Fertility approaches RIF with this kind of systematic framework rather than simply repeating the same cycle. Each investigation is tailored to what has already been tried, what has been ruled out, and what the clinical picture suggests is most worth exploring next.

There Are Answers — and There Are Paths Forward

One of the hardest things about recurrent implantation failure is the uncertainty. It can feel as though your body is simply refusing, without reason. But in the majority of cases, a cause — or a combination of contributing factors — can be identified when the right investigations are carried out.

Treating chronic endometritis with the appropriate antibiotic course, correcting a uterine septum through minimally invasive surgery, personalising transfer timing based on ERA results, or adjusting the immune environment with targeted therapy — these are not experimental approaches. They are evidence-informed steps that have helped many patients who had been told there was nothing left to try.

If you are navigating recurrent implantation failure and want a thorough, honest assessment of where things stand and what your next step should realistically be, Iswarya Fertility is here to help. Book a consultation with our fertility specialists and let us look at your case from every angle — not just the embryo side, but the full picture.

Frequently Asked Questions

How many failed transfers counts as recurrent implantation failure?

RIF is generally defined as two or more failed transfers of good-quality embryos. Some clinicians apply the definition after three failures. If you have experienced repeated failures, it is worth requesting a dedicated RIF investigation rather than proceeding with another cycle without further assessment.

Can a uterine problem be fixed before the next IVF cycle?

In many cases, yes. Polyps and submucosal fibroids can be removed via hysteroscopy, a minimally invasive procedure. Chronic endometritis can be treated with antibiotics. Once structural or infectious issues are resolved, the next transfer attempt can take place in a better-prepared uterine environment.

What is the ERA test and how is it done?

The Endometrial Receptivity Analysis (ERA) test is a biopsy of the uterine lining taken at the expected time of receptivity in a mock cycle. The sample is analysed to determine whether your endometrium is receptive, pre-receptive, or post-receptive at that point, allowing your doctor to personalise the timing of your actual embryo transfer.

Does having a thin uterine lining mean I can never carry a pregnancy?

Not necessarily. Thin lining can sometimes be improved with extended oestrogen preparation, specific medications, or procedures to improve blood flow to the endometrium. The underlying cause matters — some cases respond well to treatment, and your doctor can advise based on your specific pattern and history.

Should I consider PGT-A testing for my embryos if I have RIF?

PGT-A (genetic testing of embryos) can help rule out chromosomal abnormalities as a cause of failure, and may be recommended as part of an RIF workup. However, even chromosomally normal embryos can fail to implant if uterine factors are present, so embryo testing and uterine investigation are complementary — not one instead of the other.

Tags:#recurrent implantation failure#IVF#uterine receptivity#embryo transfer#fertility treatment
Call Us
WhatsApp